SCHEMBL4034837

SCHEMBL4034837

N#Cc1ccc(C2([C@@H](C(=O)NC3CCCCC3)C3CCCCC3)Nc3ccccc3N2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
TSHR P16473 5/20 0.47
EPHX1 P07099 2/20 0.46
NR1H4 Q96RI1 1/20 0.46
EPHX2 P34913 2/20 0.40
FASN P49327 1/20 0.39
KMT2A Q03164 4/20 0.38
HTT P42858 3/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ACKR3 P25106 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044228 0.89 TSHR (0.41) NPC1RAB9ATSHREPHX1NR1H4
SCHEMBL4042940 0.87 TSHR (0.45) NPC1RAB9ATSHREPHX1EPHX2
SCHEMBL4034826 0.85 GRM5 (0.40) NPC1RAB9ATSHRNR1H4KMT2A
SCHEMBL4042732 0.85 NR1H4 (0.44) NPC1RAB9ATSHREPHX1NR1H4
SCHEMBL4037453 0.85 EPHX1 (0.43) NPC1RAB9ATSHREPHX1KMT2A
SCHEMBL4039101 0.85 NR1H4 (0.44) NPC1RAB9ATSHREPHX1NR1H4
SCHEMBL4040005 0.85 KMT2A (0.43) NPC1RAB9ATSHREPHX1KMT2A
SCHEMBL4037032 0.85 TSHR (0.41) NPC1RAB9ATSHREPHX1NR1H4
SCHEMBL4040671 0.83 NPC1 (0.45) NPC1RAB9ATSHREPHX1EPHX2
SCHEMBL4043049 0.83 SMN1; SMN2 (0.46) NPC1RAB9ATSHREPHX1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed